Hrt Financial LP Precigen, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Precigen, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 114,461 shares of PGEN stock, worth $85,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,461

Holding current value

$85,845

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.91 - $1.88 $104,159 - $215,186	114,461 New	114,461 $108,000
Q4 2023 Feb 09, 2024	BUY	$0.89 - $1.41 $10,634 - $16,848	11,949 New	11,949 $16,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $343,671 - $680,031	-243,739 Reduced 95.94%	10,311 $21,000
Q2 2022 Aug 12, 2022	SELL	$1.15 - $2.53 $548,739 - $1.21 Million	-477,165 Reduced 65.26%	254,050 $340,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $1.4 Million - $2.91 Million	731,215 New	731,215 $1.54 Million
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $271,584 - $423,148	-76,936 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $383,910 - $503,930	76,936 New	76,936 $383,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $223,995 - $630,769	-59,732 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $209,062 - $370,338	59,732 New	59,732 $209,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

Third Security, LLC

83.5M
Shares

$62.6 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$13.5 Million
0.92% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$8.15 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$7.69 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$6.25 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account